Unknown

Dataset Information

0

Optimizing Adaptive Therapy Based on the Reachability to Tumor Resistant Subpopulation.


ABSTRACT: Adaptive therapy exploits the self-organization of tumor cells to delay the outgrowth of resistant subpopulations successfully. When the tumor has aggressive resistant subpopulations, the outcome of adaptive therapy was not superior to maximum tolerated dose therapy (MTD). To explore methods to improve the adaptive therapy's performance of this case, the tumor system was constructed by osimertinib-sensitive and resistant cell lines and illustrated by the Lotka-Volterra model in this study. Restore index proposed to assess the system reachability can predict the duration of each treatment cycle. Then the threshold of the restore index was estimated to evaluate the timing of interrupting the treatment cycle and switching to high-frequency administration. The introduced reachability-based adaptive therapy and classic adaptive therapy were compared through simulation and animal experiments. The results suggested that reachability-based adaptive therapy showed advantages when the tumor has an aggressive resistant subpopulation. This study provides a feasible method for evaluating whether to continue the adaptive therapy treatment cycle or switch to high-frequency administration. This method improves the gain of adaptive therapy by taking into account the benefits of tumor intra-competition and the tumor control of killing sensitive subpopulation.

SUBMITTER: Wang J 

PROVIDER: S-EPMC8582524 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4314682 | biostudies-literature
| S-EPMC7211445 | biostudies-literature
| S-EPMC4635519 | biostudies-literature
| S-EPMC8374079 | biostudies-literature
| S-EPMC3948467 | biostudies-other
| S-EPMC9391386 | biostudies-literature
| S-EPMC3836917 | biostudies-literature
| S-EPMC4498698 | biostudies-literature
| S-EPMC5197067 | biostudies-literature
| S-EPMC7439744 | biostudies-literature